Equity Overview
Price & Market Data
Price: $32.05
Daily Change: -$0.09 / 0.28%
Range: $31.71 - $33.64
Market Cap: $2,498,520,576
Volume: 284,075
Performance Metrics
1 Week: 2.94%
1 Month: 3.24%
3 Months: -26.83%
6 Months: -1.67%
1 Year: 61.65%
YTD: -19.05%
Company Details
Employees: 824
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.